New lotion shows promise for rare skin disorder
NCT ID NCT07538583
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a lotion called QRX003 in people with Netherton Syndrome, a rare genetic skin condition. About 16 participants aged 4 and older will apply the lotion twice daily for 12 weeks. Researchers will check if it improves skin appearance and reduces itching.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NETHERTON SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beacon Clinical Research
RECRUITINGQuincy, Massachusetts, 02169, United States
-
Center for Dermatology Clinical Research
RECRUITINGFremont, California, 94538, United States
-
Dawes Fretzin Clinical Reseacrh Group
RECRUITINGIndianapolis, Indiana, 46250, United States
-
Texas Dermatology and Laser Specialists
RECRUITINGSan Antonio, Texas, 78218, United States
-
Yale University School of Medicine
NOT_YET_RECRUITINGNew Haven, Connecticut, 06520, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental drug for rare skin disease fails to reach goal
- Scientists hunt for clues to ichthyosis in skin and blood
- Could arthritis drug humira ease rare skin disease?
- Microbiome study seeks clues in rare skin condition
- New cream shows promise for rare skin condition
- Rare skin disease mystery unraveled: new study maps netherton Syndrome's inner workings